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She scientific priorities of the National Heart, Lung,
and Blood Institute (NHBLI) are delineated in the
NHLBI Strategic Plan, which was released in
arch 2007 (1). The plan lays out a broad agenda for
overnment-funded biomedical research and training in
ardiovascular disease, lung and blood diseases, and sleep
isorders; approximately 90% of the Institute’s research
udget supports extramural researchers, through grants and
ontracts. One of the major roles of the NHLBI program
taff is to establish, implement, and evaluate specific prior-
ties identified by the Strategic Plan.
The Division of Cardiovascular Sciences oversees cardio-
ascular research supported by the NHLBI. In a later
olumn, we will describe the branches of the Division in
etail. The Population Sciences Program (PSP)* oversees
pidemiological research and trials that are specifically
oncerned with primary prevention or management of
ardiovascular risk factors.
Extramural research supported by the NHLBI can be
lassified into 5 major types:
. Investigator-initiated projects with total direct costs of
no more than $500,000 per year (e.g., R01 grants):
investigators are free to submit proposals for review
without any special pre-review consideration.
. Investigator-initiated projects with total direct costs
exceeding $500,000 in at least 1 year but not exceeding
a cap, currently set at $1.515 million in any year:
investigators must first contact the NHLBI staff for a
pre-review in order to obtain permission to submit a
formal application. The pre-review occurs on a division
level (2,3).
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C
D. Investigator-initiated projects with total direct costs
exceeding a cap of approximately $1.5 million in at least
1 year (see #2 in the preceding text): investigators must
first contact the NHLBI staff for pre-review in order to
obtain permission to submit a formal application. This
review is more extensive than category 2, with a formal
review involving leadership throughout the entire Institute.
. Institute-initiated grant programs: NHLBI program
staff members develop formal Requests for Applications
(RFAs) for research grants that address issues felt to be
of high priority by the Institute. These RFAs undergo
a process of internal review, followed by external
review by our Board of External Experts and Advisory
Council.
. Institute-initiated contracts: NHLBI program staff
members develop a formal Request for Proposals (RFP)
for contract work deemed to be of high priority by the
Institute. This typically is used for “big science projects,”
like multicenter clinical trials, major cohort studies, and
making resources (such as genotyping) available to in-
vestigators. As with RFAs, these projects undergo a
process of internal review, followed by external review by
our Board of External Experts and Advisory Council.
In a later column, we will review the processes for
pplying for large grants in detail.
To help scientific staff in our Program (PSP) articulate
ow they develop scientific priorities and make rational,
ransparent, and fair decisions, we polled them to identify
actors they use to establish priorities. Through a process
f collecting, culling, and combining factors, we identi-
In May 2009, the NHLBI merged the Division of Prevention and Population
ciences (DPPS) and the Division of Cardiovascular Diseases into the Division of
ardiovascular Sciences (DCVS). DPPS became the Population Sciences Programwithin
CVS. This paper has been written from the perspective of the reorganization.
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Table 1. We then asked staff to
apply these factors by ranking
their importance in prioritizing
a set of sample research propos-
als for large-scale projects (cat-
egories 3 and 5 in the preceding
text). We later discussed the
composite results and explored
why individuals applied specific
factors to specific projects.
The most important factor our staff identified was “im-
act on population health.” The next 4 most important
actors were “feasibility,” “relevance to the PSP mission,” the
need for or previous lack of studies on this topic,” and
quality of the proposed methods.” Some factors were not
onsidered as important in the rankings because of overlap
n the content with better-ranked factors. For example,
ince the PSP mission is subsumed within the NHLBI
trategic Plan, the factor related to the Strategic Plan did
ot fare as well. “Study cost” ranked in the middle; the
mportance of cost might be expected to be subject to
eneral budget pressures and has been a particular subject
ately as the Program considers research on costly medical
echnology.
Several of these factors coincide with other lines of
hought on research priority setting. The Institute of Med-
cine outlined and endorsed 6 criteria that are used in
riority setting at the National Institutes of Health: 1)
ublic health needs; 2) scientific quality of the research; 3)
otential for scientific progress (the existence of promising
athways and qualified investigators); 4) portfolio diversifi-
ation along the broad and expanding frontiers of research;
nd 5) adequate support of infrastructure (human capital,
Abbreviations
and Acronyms
DCVS  Division of
Cardiovascular Sciences
PSP  Population Sciences
Program
RFA  Request for
Applications
RFP  Request for Proposals
able 1 The 16 Factors Used in Considering Scientific Priority,
n Alphabetical Order
easibility
nnovation
ikelihood that entity outside of PSP would support
ultidisciplinary nature of the research
otential for impact on individual health
otential for impact on national health care expenditures
otential for impact on population health
ualifications and track record of the proposer
uality of proposed methods
uality of writing and organization of the proposal
elevance to a global (beyond U.S.) agenda
elevance to the PSP mission
elevance to the NHLBI Strategic Plan
esearch need/lack of studies
tudy cost
niqueness or timeliness of opportunityHLBI  National Heart, Lung, and Blood Institute; PSP  Population Sciences Program.quipment and instrumentation, and facilities) (4). The first
criteria, in particular, echo the top-ranked PSP factors.
he World Health Organization budget is set, in large part
and at least in principle), based on evidence of burden of
isease (5). Some of our staff’s thoughts are also consonant
ith another recently described construct for making re-
earch priority decisions within a context of insufficient
vidence for clinical decision making. Chalkidou et al. (6)
uggest 3 major questions: 1) Is there a net benefit? 2) Is it
orthwhile to collect additional evidence? and 3) Should we
ait to get this information? The first 2 questions overlap
ur identified factors of “impact of population health,”
relevance to the PSP mission,” and “previous lack of studies
n this topic.”
It is critical to point out that our work in establishing,
mplementing, and evaluating scientific priorities is dis-
inct from peer review. Our staff places high value on peer
eview, particularly to determine scientific merit of spe-
ific proposals or ideas, and we do not try to supplant this
rocess. Some of the factors that peer reviewers use to
valuate proposals overlap with the factors our staff uses
o consider overarching priorities; perhaps the most
elevant overlapping factor is “feasibility,” as this issue
learly directly ties into our responsibility as stewards of
ublic monies. Nonetheless, in general, factors used to
stablish scientific priorities will differ based on the
pecific mission of the funding agency or group, and
ence transcends the specific strengths or weaknesses of
ny one specific scientific idea or proposal.
It is also critical to point out that the establishment,
mplementation, and evaluation of scientific priorities are
ot activities that the NHLBI staff members undertake in
solation. Just as the NHLBI Strategic Plan was con-
eived and developed in close consultation with the
xtramural scientific community, activities of program
taff also occur in nearly constant communication with
xtramural scientists. There are, for example, formal
echanisms for this, such as NHLBI-sponsored working
roups or workshops; in other cases, ongoing dialogue
bout scientific priorities occurs within other settings,
uch as scientific meetings. In presenting this summary of
ur own internal discussions about how best to consider
cientific priorities, we hope to stimulate ongoing dia-
ogue with the scientific community not only on specific
elds of endeavor but also on how best we can work
ogether to ensure that NHLBI taxpayer-supported funds
re best used in the public interest.
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